Fully Humanized Neutralizing Antibodies to Interleukin-8 (ABX-IL8) Inhibit Angiogenesis, Tumor Growth, and Metastasis of Human Melanoma

This publication has 46 references indexed in Scilit:

• Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo
  Oncogene, 2001
• Antibody therapy of lymphoma
  Expert Opinion on Pharmacotherapy, 2001
• Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenograftsin vivo
  International Journal of Cancer, 2000
• Expression of interleukin-8 detected byin situ hybridization correlates with worse prognosis in primary cutaneous melanoma
  The Journal of Pathology, 1999
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• The implications of angiogenesis for the biology and therapy of cancer metastasis
  Cell, 1994
• Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
  The Journal of Experimental Medicine, 1994
• Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
  Science, 1992
• Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo
  Journal of Cellular Physiology, 1992
• Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8
  Biochemical and Biophysical Research Communications, 1990